Intellia Therapeutics is a genome editing company focused on developing therapeutics utilizing a biological tool known as Clustered, Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR associated 9 (Cas9). This is a technology for genome editing, the process of altering selected sequences of genomic deoxyribonucleic acid. The company utilizes its CRISPR/Cas9 platform across two areas: in vivo applications, in which CRISPR/Cas9 is therapy, delivered to target cells within the body; and ex vivo applications, in which CRISPR/Cas9 creates therapy of engineered human cells.

Quest Resource Holding is a provider of reuse, recycling, and disposal services. The company provides businesses across industry sectors with single source solutions for the reuse, recycling, and disposal of a variety of waste streams and recyclables generated by their operations. The company's customers are multi-location businesses for which it creates, implements, and manages customer-specific programs for the collection, processing, recycling, disposal, and tracking of waste streams and recyclables. The company's sustainability programs include planning, writing policies and procedures, LEED certification, life cycle assessment, energy modeling, building commissioning, and carbon emission reduction reporting.

Shenandoah Telecommunications provide wireless personal communications service under the Sprint brand, and telephone service, cable television, unregulated communications equipment sales and services, and internet access under the Shentel brand. The company's reportable segments include: Wireless, which provides personal communications services through a digital wireless telephone and data network; Cable, which video, internet and voice services to customers in franchise areas, and leases fiber optic facilities throughout its service area; and Wireline, which provides regulated and unregulated voice services, internet broadband, long distance access services, and leases fiber optic facilities.

TriplePoint Venture Growth BDC is an externally managed, closed-end, non-diversified management investment company. The company's investment objective is provide stockholders with current income and, to a lesser extent, capital appreciation by primarily lending with warrant investments to venture growth stage companies focused in technology, life sciences and other industries that are backed by TriplePoint Capital LLC's select group of venture capital investors.